Many studies have reported an association of subclinical inflammatory markers with increased levels of IL-6, C-reactive protein, plasminogen activator inhibitor-1, and the future development of T2D and CVD [32,33]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.